Skip to content
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Homepage
Open navigation
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Posts in: medicine
biofuel
medicine
press clippings
science
Biomass Magazine: Why Use Living Cells? NLR Is Making Chemicals With Enzymes Alone
June 29, 2026
heltzen
press release
investor
medicine
science
cannabinoids
korman
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery
June 24, 2026
investor
medicine
press clippings
cannabinoids
Rolling Stone: Next-gen cannabinoids - the innovative race to manufacture compounds
May 15, 2026
press release
nutraceuticals
medicine
press clippings
video
science
podcast
perriman
NCT
eXoZymes CCO, Damien Perriman, outlines NCTx strategy and the commercial path for cell-free biomanufacturing on Grow Everything podcast
April 10, 2026
investor
nutraceuticals
medicine
press clippings
video
perriman
NCT
Nasdaq: Damien Perriman interview on NCT
April 2, 2026
investor
nutraceuticals
medicine
video
NCT
cannabinoids
Transcript: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026
April 1, 2026
biofuel
medicine
press clippings
science
NLR: Why Use Living Cells? NLR Is Making Chemicals With Enzymes Alone
March 26, 2026
investor
nutraceuticals
medicine
perriman
NCT
EXOZ investor update: eXoZymes de-risks scale-up with Cayman Chemical, validating tech transfer with pharma-grade output
March 18, 2026
press release
nutraceuticals
medicine
video
perriman
NCT
Video interview: Successful pilot scale run with Cayman Chemical validates eXoZymes' technology and scalability
March 18, 2026
press release
nutraceuticals
medicine
perriman
NCT
eXoZymes’ CCO Damien Perriman to Present a NCT solution at next week’s MISTA Symposium
March 12, 2026
Previous page
Page 1 of 2
Next page